Atreca, Inc. Selling, General and Administrative (SG&A) Expenses Growth

Selling, General and Administrative (SG&A) Expenses Growth of BCEL for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative (SG&A) Expenses Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative (SG&A) Expenses Growth for the quarter ending September 30, 2022 was -17.61% (a -3189.47% decrease compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative (SG&A) Expenses Growth decreased by -275.22%
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2021 was 19.08% (a -62.12% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2020 was 50.37% (a -67.03% decrease from previous year)
  • Annual Selling, General and Administrative (SG&A) Expenses Growth for 2019 was 152.76% (a 178.96% increase from previous year)
  • Twelve month Selling, General and Administrative (SG&A) Expenses Growth ending September 30, 2022 was -0.16% (a -101.27% decrease compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative (SG&A) Expenses Growth decreased by -100.84% year-over-year
Trailing Selling, General and Administrative (SG&A) Expenses Growth for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
-0.16% 12.64% 18.91% 19.08%
Visit stockrow.com/BCEL for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative (SG&A) Expenses Growth of Atreca, Inc.

Most recent Selling, General and Administrative (SG&A) Expenses Growthof BCEL including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative (SG&A) Expenses Growth of Atreca, Inc.

Atreca, Inc. Selling, General and Administrative (SG&A) Expenses Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -17.61% 0.57% 10.04%
2021 10.05% 32.99% 24.36% 9.8% 19.08%
2020 -4.14% 35.98% 82.58% 182.88% 50.37%
2019 269.39% 198.04% -45.23% -64.65% 152.76%
2018 -72.93% -66.45% 54.76%
2017 -35.38%

Business Profile of Atreca, Inc.

Sector: Healthcare
Industry: Biotechnology